This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages without signing in


Last reviewed dd mmm yyyy. Last edited dd mmm yyyy

Authoring team

Treatment with ramipril resulted in the following risk reductions:

  • 25% (p=0.0004) for combined primary outcome
  • 22% for MI
  • 33% for stroke
  • 37% for cardiovascular death
  • 17% revascularisation
  • 24% (p=0.027) for overt nephropathy

Create an account to add page annotations

Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.